Home
About
Investors
- Investment Philosophy
- Client Portal
Corporates
Research
- Canary Research Reports
- Internal Research Notes
Listed
Unlisted
- DekkoSecure
Open an Account
Contact
- Contact Us
- Newsletter
Canary Login

Incannex Psi-GAD clinical development overview

Aug 13, 2021

ASX News Incannex Healthcare (ASX:IHL)

Send
Share
Share

Related Posts

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

Jul 13, 2023 |

Incannex Healthcare (ASX:IHL)

Nyrada – European Patent to be Granted for Cholesterol-Lowering Drug

May 17, 2022 |

ASX News, Nyrada Inc (ASX:NYR)

Confirmation of Capital Structure – CHESS Depositary Interests on Issue

Jun 29, 2021 |

ASX News, Nyrada Inc (ASX:NYR)

HARVEST ACTIVITY REPORT – JUNE QUARTER 2022

Jul 28, 2022 |

ASX News, Harvest Technology Group (ASX:HTG)

Back to Incannex Healthcare (ASX:IHL)

GET INVESTMENT OPPORTUNITIES OR
RAISE CAPITAL

Contact Us

Home
About
Investors
- Investment Philosophy
Corporates

Listed
- Mt Malcolm Mines NL
- Nyrada Inc
Unlisted
- DekkoSecure

Contact

CANARY CAPITAL PTY LTD

ABN 18 618 657 640
CAR number 1254859
Of BR Securities Australia Pty Ltd
Holder of AFSL 456663
Level 16/9 Castlereagh St,
Sydney NSW 2000,
AUSTRALIA

P: (02) 9133 1325

Privacy Policy
Terms of Service
Disclaimer
Financial Services Guide

© 2026 Canary Capital | Web Development by Argon

Client Login

Username or Email

Password

Remember Me

Lost your password?

Welcome.

You now have full access to our research reports and will receive future updates from Canary Capital via email.

Access Canary Capital Research

Sign up to our mailing list to access our research reports.

By submitting your details, you agree to our Terms of Service.

"*" indicates required fields

Name*

First Last

Email*

Phone Number*

Consent*

I agree to receive research reports and updates from Canary Capital*

Δ